| Biomarkers for prognosis and treatment response in COVID-19 patients G Bivona, L Agnello, M Ciaccio Annals of laboratory medicine 41 (6), 540, 2021 | 140 | 2021 |
| The immunological implication of the new vitamin D metabolism G Bivona, L Agnello, M Ciaccio Central European Journal of Immunology 43 (3), 331-334, 2018 | 119 | 2018 |
| Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19) M Ciaccio, L Agnello Diagnosis 7 (4), 365-372, 2020 | 110 | 2020 |
| Lo Sasso L Agnello, C Scazzone, P Ragonese, G Salemi B, 2020 | 109 | 2020 |
| Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona, CM Gambino, ... Diagnostics 11 (7), 1135, 2021 | 94 | 2021 |
| COVID-19 and Alzheimer’s disease M Ciaccio, B Lo Sasso, C Scazzone, CM Gambino, AM Ciaccio, G Bivona, ... Brain sciences 11 (3), 305, 2021 | 93 | 2021 |
| Non-skeletal activities of vitamin D: from physiology to brain pathology G Bivona, L Agnello, C Bellia, G Iacolino, C Scazzone, B Lo Sasso, ... Medicina 55 (7), 341, 2019 | 91 | 2019 |
| Galectin-3 in acute coronary syndrome L Agnello, G Bivona, BL Sasso, C Scazzone, V Bazan, C Bellia, M Ciaccio Clinical biochemistry 50 (13-14), 797-803, 2017 | 91 | 2017 |
| Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children L Agnello, C Bellia, M Di Gangi, BL Sasso, L Calvaruso, G Bivona, ... Clinical biochemistry 49 (1-2), 47-50, 2016 | 83 | 2016 |
| Cerebrospinal fluid analysis in multiple sclerosis diagnosis: an update B Lo Sasso, L Agnello, G Bivona, C Bellia, M Ciaccio Medicina 55 (6), 245, 2019 | 72 | 2019 |
| The value of a complete blood count (CBC) for sepsis diagnosis and prognosis L Agnello, RV Giglio, G Bivona, C Scazzone, CM Gambino, A Iacona, ... Diagnostics 11 (10), 1881, 2021 | 68 | 2021 |
| Vitamin D and genetic susceptibility to multiple sclerosis C Scazzone, L Agnello, G Bivona, B Lo Sasso, M Ciaccio Biochemical genetics 59, 1-30, 2021 | 67 | 2021 |
| Vitamin D and immunomodulation: is it time to change the reference values? G Bivona, L Agnello, M Ciaccio Annals of Clinical & Laboratory Science 47 (4), 508-510, 2017 | 65 | 2017 |
| Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department L Agnello, G Bivona, M Vidali, C Scazzone, RV Giglio, G Iacolino, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (11), 1951-1957, 2020 | 59 | 2020 |
| Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients L Agnello, C Scazzone, P Ragonese, G Salemi, B Lo Sasso, R Schillaci, ... Neurological Sciences 37, 261-267, 2016 | 56 | 2016 |
| Procalcitonin and community-acquired pneumonia (CAP) in children B Giulia, A Luisa, S Concetta, LS Bruna, B Chiara, C Marcello Clinica Chimica Acta 451, 215-218, 2015 | 56 | 2015 |
| Short-term changes in gal 3 circulating levels after acute myocardial infarction G Bivona, C Bellia, BL Sasso, L Agnello, C Scazzone, G Novo, M Ciaccio Archives of Medical Research 47 (7), 521-525, 2016 | 53 | 2016 |
| VDBP, CYP27B1, and 25-hydroxyvitamin D gene polymorphism analyses in a group of Sicilian multiple sclerosis patients L Agnello, C Scazzone, B Lo Sasso, C Bellia, G Bivona, S Realmuto, ... Biochemical genetics 55, 183-192, 2017 | 51 | 2017 |
| Diagnostic and prognostic value of H-FABP in acute coronary syndrome: Still evidence to bring G Bivona, L Agnello, C Bellia, BL Sasso, M Ciaccio Clinical biochemistry 58, 1-4, 2018 | 49 | 2018 |
| Association of CYP2R1 rs10766197 with MS risk and disease progression C Scazzone, L Agnello, P Ragonese, B Lo Sasso, C Bellia, G Bivona, ... Journal of neuroscience research 96 (2), 297-304, 2018 | 48 | 2018 |
